InvestorsHub Logo
Followers 29
Posts 2189
Boards Moderated 1
Alias Born 05/09/2013

Re: RareEarths post# 20955

Wednesday, 01/18/2017 6:30:11 PM

Wednesday, January 18, 2017 6:30:11 PM

Post# of 32010
Yeah its really a wonder drug and the reason I know is that my nephew swears by it. Its been game changing in so many ways for him, but he would have never known about it without me.

The biggest issue is that 99% of the diabetic community has no idea WTF is Afrezza. IMO they need a partner that wants to make this work and whomever gets involved doesn't have another product that causes conflict of interest.

The other problem I have is that Matt said last January that once SNY terminated he had several calls from other players interested in partnering. Ok maybe at that time it was advantageous to cut a deal, but now with all the added data, insurance coverage, SNY settlement and knowledge on the dosing front they could do a better partnership.

MNKD was offered $500M for 50% last year, so why not cut a similar deal for 25% as the story is that much further along? Waiting to hire, train and hit the road again with a new sales force is still another 6-9 months away. Aggravates me a bit that Mike C was patting himself on the back for getting the contract sales reps up and running in a short period of time. Well it failed, so what's next Mike and can this sales team have more success?

Like I said its a winner, but we need to run and not walk anymore as time is important. Sell 25% of the company and lets get going. Social Media is a no brainer and these guys need to get going.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News